Optogenetics : the new molecular approach to control functions of neural cells in epilepsy, depression and tumors of the central nervous system
The optogenetic tools have been described as valuable techniques to study neural activity through light stimulation, as well as potential neuromodulator approaches in the management of several central nervous system (CNS) diseases. Since the first bacteriorhodopsin protein described as a single-component light-activated regulator of transmembrane ion flow description, in 1980's, the focus has been on channel proteins for neurobiology; however, the advances in engineering techniques showed involvement changes in cellular biological behavior in several types of proteins involved in cell cytoskeleton regulation, motility and gene expression. Although the use of this technology has been published in many papers, a question still remains regarding real results and potential clinical applicability in CNS diseases, as well as the publications scarcity that systematically analyses the published results. Lastly, the aim of this review is to discuss the experimental results, molecular mechanisms and potential clinical applications of optogenetic tools in epilepsy and depression treatment, as well as its applicability in the treatment of CNS tumors.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
American journal of cancer research - 8(2018), 10 vom: 27., Seite 1900-1918 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Camporeze, Bruno [VerfasserIn] |
|---|
| Themen: |
Central nervous system tumors |
|---|
| Anmerkungen: |
Date Revised 03.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM290495008 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM290495008 | ||
| 003 | DE-627 | ||
| 005 | 20240403232007.0 | ||
| 007 | tu | ||
| 008 | 231225s2018 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1362.xml |
| 035 | |a (DE-627)NLM290495008 | ||
| 035 | |a (NLM)30416844 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Camporeze, Bruno |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Optogenetics |b the new molecular approach to control functions of neural cells in epilepsy, depression and tumors of the central nervous system |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Revised 03.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a The optogenetic tools have been described as valuable techniques to study neural activity through light stimulation, as well as potential neuromodulator approaches in the management of several central nervous system (CNS) diseases. Since the first bacteriorhodopsin protein described as a single-component light-activated regulator of transmembrane ion flow description, in 1980's, the focus has been on channel proteins for neurobiology; however, the advances in engineering techniques showed involvement changes in cellular biological behavior in several types of proteins involved in cell cytoskeleton regulation, motility and gene expression. Although the use of this technology has been published in many papers, a question still remains regarding real results and potential clinical applicability in CNS diseases, as well as the publications scarcity that systematically analyses the published results. Lastly, the aim of this review is to discuss the experimental results, molecular mechanisms and potential clinical applications of optogenetic tools in epilepsy and depression treatment, as well as its applicability in the treatment of CNS tumors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Optogenetic tools | |
| 650 | 4 | |a central nervous system tumors | |
| 650 | 4 | |a depression | |
| 650 | 4 | |a epilepsy | |
| 650 | 4 | |a light signaling | |
| 700 | 1 | |a Manica, Bruno Alcântara |e verfasserin |4 aut | |
| 700 | 1 | |a Bonafé, Gabriel Alves |e verfasserin |4 aut | |
| 700 | 1 | |a Ferreira, Jivago Jordão Camargos |e verfasserin |4 aut | |
| 700 | 1 | |a Diniz, Aurélio Lourenço |e verfasserin |4 aut | |
| 700 | 1 | |a de Oliveira, Carlos Tadeu Parisi |e verfasserin |4 aut | |
| 700 | 1 | |a Mathias Junior, Luis Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a de Aguiar, Paulo Henrique Pires |e verfasserin |4 aut | |
| 700 | 1 | |a Ortega, Manoela Marques |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of cancer research |d 2011 |g 8(2018), 10 vom: 27., Seite 1900-1918 |w (DE-627)NLM207988722 |x 2156-6976 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2018 |g number:10 |g day:27 |g pages:1900-1918 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2018 |e 10 |b 27 |h 1900-1918 | ||